Last update :
08/05/2024
InfoStab
Infostab
List of drugs
List of drugs
Summary lists
Summary lists
Search for compatibilities
Search for compatibilities
Y-site compatibility table
Y-site compatibility table
References
References
Research teams
Research teams
Valistab
Valistab
Poster
Poster
Links
Links
Sponsors
Sponsors
Authors
Authors
User’s guide
User’s guide
Newsletter
Newsletter
Anti-inflammatory   Dexamethasone sodium phosphate  
Injection
Oral solution
Stability in solutions Stability of mixtures Factors which affect stability Compatibility Route of administration References Pdf
   Chemical structure  

Tradename   Tradename     

Trade names are indicative and excipients composition can be different depending on the country and manufacturers
Aacidexam Belgium, Luxembourg
Alin Mexico
Aquason Iran
Bexine Mexico
Decadron Argentina, Brazil, Greece, Italy, Mexico, Netherlands, United States of America, Venezuela
Decasone Republic of South Africa
Dexabene Austria, Germany
Dexaven Poland
Fortecortin Austria, Germany, Spain, Switzerland
Onadron Turkey
Oradexon Finland, Netherlands, Portugal, Saudi Arabia
Soldesanil Greece
Stability of mixtures   Injection   Stability of mixtures : Dexamethasone sodium phosphate     
Container Solvent Concentration Compound Temperature Storage Duration of stability References
Glass NaCl 0,9% or Glucose 5% 4 mg/ml
Injection   Dexamethasone sodium phosphate   
Injection   Cefpirome sulfate 50 mg/ml
23°C
8 Hour
Protect from light 280
Level of evidence B+
Glass NaCl 0,9% or Glucose 5% 0,34 mg/ml
Injection   Dexamethasone sodium phosphate   
Injection   Ondansetron hydrochloride 0,14 & 0,45 mg/ml
25°C
24 Hour
Light 25
Glass Sodium chloride 0,9% 0,12 mg/ml
Injection   Dexamethasone sodium phosphate   
Injection   Granisetron hydrochloride 0,5 mg/ml
20°C-23°C
4 Hour
Protect from light 57
Level of evidence A+
Glass Sodium chloride 0,9% 0,05 & 0,1 & 0,2 mg/ml
Injection   Dexamethasone sodium phosphate   
Injection   Azasetron 0,1 mg/ml
25°C
48 Hour
Protect from light 4301
Level of evidence A
Glass Sodium chloride 0,9% 0,05 & 0,1 & 0,2 mg/ml
Injection   Dexamethasone sodium phosphate   
Injection   Azasetron 0,1 mg/ml
4°C
14 Day
Protect from light 4301
Level of evidence A
Glass Glucose 5% 0,28 mg/ml
Injection   Dexamethasone sodium phosphate   
Injection   Lorazepam 0,028 mg/ml
Injection   Ondansetron hydrochloride 0,44 mg/ml
25°C
24 Hour
Light 25
Glass Ringer’s lactate solution 4 mg/ml
Injection   Dexamethasone sodium phosphate   
Injection   Cefpirome sulfate 50 mg/ml
23°C
8 Hour
Protect from light 280
Level of evidence B+
Glass Sodium chloride 0,45% 4 mg/ml
Injection   Dexamethasone sodium phosphate   
Injection   Cefpirome sulfate 50 mg/ml
23°C
8 Hour
Protect from light 280
Level of evidence B+
Glass None 0,178 mg/ml
Injection   Dexamethasone sodium phosphate   
Injection   Rolapitant 1,6 mg/ml
Injection   Palonosetron hydrochloride 2,1 µg/ml
2-8°C
48 Hour
Protect from light 4062
Level of evidence C+
Glass None 0,093 mg/ml
Injection   Dexamethasone sodium phosphate   
Injection   Rolapitant 1,6 mg/ml
Injection   Palonosetron hydrochloride 2,1 µg/ml
2-8°C
48 Hour
Protect from light 4062
Level of evidence C+
Glass None 0,086 mg/ml
Injection   Dexamethasone sodium phosphate   
Injection   Rolapitant 1,7 mg/ml
20-25°C
6 Hour
Light 3927
Level of evidence A+
Glass None 0,170 mg/ml
Injection   Dexamethasone sodium phosphate   
Injection   Rolapitant 1,7 mg/ml
20-25°C
6 Hour
Light 3927
Level of evidence A+
Glass None 0,093 mg/ml
Injection   Dexamethasone sodium phosphate   
Injection   Rolapitant 1,6 mg/ml
Injection   Palonosetron hydrochloride 2,1 µg/ml
20-25°C
24 Hour
Light 4062
Level of evidence C+
Glass None 0,178 mg/ml
Injection   Dexamethasone sodium phosphate   
Injection   Rolapitant 1,6 mg/ml
Injection   Palonosetron hydrochloride 2,1 µg/ml
20-25°C
24 Hour
Light 4062
Level of evidence C+
Polyvinyl chloride NaCl 0,9% or Glucose 5% 0,43 mg/ml
Injection   Dexamethasone sodium phosphate   
Injection   Ondansetron hydrochloride 0,15 mg/ml
15-25°C
28 Day
Protect from light 23
Level of evidence A
Polyvinyl chloride NaCl 0,9% or Glucose 5% 0,43 mg/ml
Injection   Dexamethasone sodium phosphate   
Injection   Ondansetron hydrochloride 0,15 mg/ml
2-8°C
28 Day
Protect from light 23
Level of evidence A
Polyvinyl chloride NaCl 0,9% or Glucose 5% 0.074 >> 0.345 mg/ml
Injection   Dexamethasone sodium phosphate   
Injection   Granisetron hydrochloride 0,056 mg/ml
22°C
3 Day
Protect from light 29
Polyvinyl chloride NaCl 0,9% or Glucose 5% 0,08 & 0,20 mg/ml
Injection   Dexamethasone sodium phosphate   
Injection   Granisetron hydrochloride 0,02 & 0,06 mg/ml
23°C
35 Day
Not specified 1633
Level of evidence A
Polyvinyl chloride NaCl 0,9% or Glucose 5% 0,080 - 0,600 mg/ml
Injection   Dexamethasone sodium phosphate   
Injection   Granisetron hydrochloride 0,010 - 0,040 mg/ml
23°C-25°C
14 Day
Protect from light 27
Level of evidence B
Polyvinyl chloride NaCl 0,9% or Glucose 5% 0,28 mg/ml
Injection   Dexamethasone sodium phosphate   
Injection   Ondansetron hydrochloride 0,14 & 0,45 mg/ml
25°C
24 Hour
Light 25
Polyvinyl chloride NaCl 0,9% or Glucose 5% 0,2 & 0,4 mg/ml
Injection   Dexamethasone sodium phosphate   
Injection   Palonosetron hydrochloride 5 µg/ml
25°C
48 Hour
Light 1932
Level of evidence A+
Polyvinyl chloride NaCl 0,9% or Glucose 5% 0,08 - 0,60 mg/ml
Injection   Dexamethasone sodium phosphate   
Injection   Granisetron hydrochloride 0,01 - 0,04 mg/ml
4°C
14 Day
Protect from light 27
Level of evidence B
Polyvinyl chloride NaCl 0,9% or Glucose 5% 0,2 & 0,4 mg/ml
Injection   Dexamethasone sodium phosphate   
Injection   Palonosetron hydrochloride 5 µg/ml
4°C
14 Day
Protect from light 1932
Level of evidence A+
Polyvinyl chloride NaCl 0,9% or Glucose 5% 0,08 & 0,20 mg/ml
Injection   Dexamethasone sodium phosphate   
Injection   Granisetron hydrochloride 0,02 & 0,06 mg/ml
4°C
35 Day
Protect from light 1633
Level of evidence A
Polyvinyl chloride Sodium chloride 0,9% 0,02 & 0,4 mg/ml
Injection   Dexamethasone sodium phosphate   
Injection   Ondansetron hydrochloride 0,1 >> 0,4 mg/ml
2-6°C
30 Day
Protect from light 30
Level of evidence B
Polyvinyl chloride Sodium chloride 0,9% 0,2 & 0,4 mg/ml
Injection   Dexamethasone sodium phosphate   
Injection   Ondansetron hydrochloride 0,1 >> 0,64 mg/ml
2-6°C
30 Day
Protect from light 30
Level of evidence B
Polyvinyl chloride Sodium chloride 0,9% 0.2 & 0.4 mg/ml
Injection   Dexamethasone sodium phosphate   
Injection   Ondansetron hydrochloride 0,1 >> 0,4 mg/ml
22°C-23°C
48 Hour
Protect from light 30
Level of evidence B
Polyvinyl chloride Sodium chloride 0,9% 0,2 & 0,4 mg/ml
Injection   Dexamethasone sodium phosphate   
Injection   Ondansetron hydrochloride 0,1 >> 0,64 mg/ml
22°C-23°C
48 Hour
Protect from light 30
Level of evidence B
Polyethylene Glucose 5% 0,09 mg/ml
Injection   Dexamethasone sodium phosphate   
Injection   Ondansetron hydrochloride 0,09 mg/ml
- 20°C
90 Day
Protect from light 3174
Polyethylene Glucose 5% 0,09 mg/ml
Injection   Dexamethasone sodium phosphate   
Injection   Ondansetron hydrochloride 0,09 mg/ml
2-8°C
90 Day
Not specified 3174
Polypropylene NaCl 0,9% or Glucose 5% 0,33 mg/ml
Injection   Dexamethasone sodium phosphate   
Injection   Palonosetron hydrochloride 25 µg/ml
25°C
48 Hour
Light 1932
Level of evidence A+
Polypropylene NaCl 0,9% or Glucose 5% 0,33 mg/ml
Injection   Dexamethasone sodium phosphate   
Injection   Palonosetron hydrochloride 25 µg/ml
4°C
14 Day
Protect from light 1932
Level of evidence A+
Polypropylene Sodium chloride 0,9% 0,07 mg/ml
Injection   Dexamethasone sodium phosphate   
Injection   Ketamine hydrochloride 3,6 & 42,8 mg/ml
23°C
8 Day
Light 2022
Level of evidence A
Polypropylene Sodium chloride 0,9% 0.33>>3.33 mg/ml
Injection   Dexamethasone sodium phosphate   
Injection   Tramadol hydrochloride 8.33>>33.33 mg/ml
25°C
5 Day
Protect from light 2211
Level of evidence A+
Polypropylene Sodium chloride 0,9% 0.33>>3.33 mg/ml
Injection   Dexamethasone sodium phosphate   
Injection   Furosemide 3.33>>10 mg/ml
25°C
5 Day
Protect from light 2205
Level of evidence C
Polypropylene Sodium chloride 0,9% 0.27 mg/ml
Injection   Dexamethasone sodium phosphate   
Injection   Lorazepam 0.16 mg/ml
Injection   Diphenhydramine hydrochloride 4 mg/ml
25°C
48 Hour
Light 2132
Level of evidence A+
Polypropylene Sodium chloride 0,9% 0,07 mg/ml
Injection   Dexamethasone sodium phosphate   
Injection   Ketamine hydrochloride 3,6 & 42,8 mg/ml
37°C
8 Day
Light 2022
Level of evidence A
Polypropylene Sodium chloride 0,9% 0,07 mg/ml
Injection   Dexamethasone sodium phosphate   
Injection   Ketamine hydrochloride 3,6 & 42,8 mg/ml
4°C
8 Day
Light 2022
Level of evidence A
Polypropylene Sodium chloride 0,9% 0.33>>3.33 mg/ml
Injection   Dexamethasone sodium phosphate   
Injection   Furosemide 3.33>>10 mg/ml
5°C
5 Day
Protect from light 2205
Level of evidence C
Polyolefine NaCl 0,9% or Glucose 5% 0,1 mg/ml
Injection   Dexamethasone sodium phosphate   
Injection   Ondansetron hydrochloride 0,08 mg/ml
23-27°C
48 Hour
Light 3981
Level of evidence A+
Polyolefine NaCl 0,9% or Glucose 5% 0,2 mg/ml
Injection   Dexamethasone sodium phosphate   
Injection   Ondansetron hydrochloride 0,08 mg/ml
23-27°C
48 Hour
Light 3981
Level of evidence A+
Polyolefine NaCl 0,9% or Glucose 5% 0,2 mg/ml
Injection   Dexamethasone sodium phosphate   
Injection   Palonosetron hydrochloride 2.5 µg/ml
23-27°C
48 Hour
Light 3981
Level of evidence A+
Polyolefine NaCl 0,9% or Glucose 5% 0,1 mg/ml
Injection   Dexamethasone sodium phosphate   
Injection   Palonosetron hydrochloride 2.5 µg/ml
23-27°C
48 Hour
Light 3981
Level of evidence A+
Polyolefine NaCl 0,9% or Glucose 5% 0,1 mg/ml
Injection   Dexamethasone sodium phosphate   
Injection   Ramosetron 3 µg/ml
23-27°C
48 Hour
Light 3981
Level of evidence A+
Polyolefine NaCl 0,9% or Glucose 5% 0.2 mg/ml
Injection   Dexamethasone sodium phosphate   
Injection   Ramosetron 3 µg/ml
23-27°C
48 Hour
Light 3981
Level of evidence A+
Polyolefine Sodium chloride 0,9% 0.1 mg/ml
Injection   Dexamethasone sodium phosphate   
Injection   Alizapride hydrochloride 1 mg/ml
2-8°C
30 Day
Not specified 3925
Level of evidence A+
Polyolefine Sodium chloride 0,9% 0.1 mg/ml
Injection   Dexamethasone sodium phosphate   
Injection   Ondansetron hydrochloride 0.08 mg/ml
2-8°C
30 Day
Not specified 3925
Level of evidence A+
Polyolefine Sodium chloride 0,9% 0,2 mg/ml
Injection   Dexamethasone sodium phosphate   
Injection   Tropisetron hydrochloride 0,05 mg/ml
23-27°C
48 Hour
Light 3981
Level of evidence A+
Polyolefine Sodium chloride 0,9% 0,1 mg/ml
Injection   Dexamethasone sodium phosphate   
Injection   Tropisetron hydrochloride 0,05 mg/ml
23-27°C
48 Hour
Light 3981
Level of evidence A+
Polyolefine Sodium chloride 0,9% 0,1 mg/ml
Injection   Dexamethasone sodium phosphate   
Injection   Dolasetron mesylate 1 mg/ml
23-27°C
48 Hour
Light 3981
Level of evidence A+
Polyolefine Sodium chloride 0,9% 0,2 mg/ml
Injection   Dexamethasone sodium phosphate   
Injection   Dolasetron mesylate 1 mg/ml
23-27°C
48 Hour
Light 3981
Level of evidence A+
Polyolefine Sodium chloride 0,9% 0,1 mg/ml
Injection   Dexamethasone sodium phosphate   
Injection   Azasetron 0,2 mg/ml
23-27°C
48 Hour
Light 3981
Level of evidence A+
Polyolefine Sodium chloride 0,9% 0,2 mg/ml
Injection   Dexamethasone sodium phosphate   
Injection   Azasetron 0,2 mg/ml
23-27°C
48 Hour
Light 3981
Level of evidence A+
Polyolefine Sodium chloride 0,9% 0,05 & 0,1 & 0,2 mg/ml
Injection   Dexamethasone sodium phosphate   
Injection   Azasetron 0,1 mg/ml
25°C
48 Hour
Protect from light 4301
Level of evidence A
Polyolefine Sodium chloride 0,9% 0,05 & 0,1 & 0,2 mg/ml
Injection   Dexamethasone sodium phosphate   
Injection   Azasetron 0,1 mg/ml
4°C
14 Day
Protect from light 4301
Level of evidence A
Polypropylen Syringe NaCl 0,9% or Glucose 5% 0,2 & 1 mg/ml
Injection   Dexamethasone sodium phosphate   
Injection   Granisetron hydrochloride 0,150 mg/ml
22°C
3 Day
Protect from light 29
Cristal Zenith® None 0,170 mg/ml
Injection   Dexamethasone sodium phosphate   
Injection   Rolapitant 1,7 mg/ml
20-25°C
6 Hour
Light 3927
Level of evidence A+
Cristal Zenith® None 0,086 mg/ml
Injection   Dexamethasone sodium phosphate   
Injection   Rolapitant 1,7 mg/ml
20-25°C
6 Hour
Light 3927
Level of evidence A+
Not specified Sodium chloride 0,9% 0,16 mg/ml
Injection   Dexamethasone sodium phosphate   
Injection   Metoclopramide hydrochloride 1,6 mg/ml
Injection   Diphenhydramine hydrochloride 2 mg/ml
25°C
48 Hour
Light 3779
Level of evidence D
  Mentions Légales